Taylor Andrew Lawrence

Taylor Andrew Lawrence is listed in filings as Chief Financial Officer at Orchestra BioMed Holdings, Inc.. This profile follows SEC Form 4 activity through May 29, 2026, including purchase activity. Recent filings connect the profile to Orchestra BioMed Holdings, Inc. (OBIO). The current snapshot covers public activity from Dec 13, 2024 to May 29, 2026. Reported amounts are shown as $12.2K to $40.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.